Technical Analysis for APLI - Appili Therapeutics Inc

Grade Last Price % Change Price Change
D 0.035 16.67% 0.005
APLI closed up 16.67 percent on Thursday, March 28, 2024, on 22 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 16.67%
Gapped Down Weakness 16.67%
Lower Bollinger Band Touch Weakness 16.67%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 15 hours ago
Rose Above 50 DMA about 15 hours ago
Rose Above 20 DMA about 15 hours ago
Rose Above 10 DMA about 15 hours ago
Up 1 ATR about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Appili Therapeutics Inc Description

Appili Therapeutics Inc is a Canada-based anti-infective pharmaceutical development company. The Company focuses on identifying, acquiring and advancing therapeutics for infectious disease. The Company is engaged in developing strategies to develop new classes of antibiotics and anti-infectives to the clinic to improve treatment and health of patients suffering from infection. The Company has over two anti-infective programs, which include ATI-1501 and ATI-1503. The Company's ATI-1501 is a taste-masked treatment for clostridium difficile infection. The Company's ATI-1503 is an antibiotic with a potential to treat Gram-negative infections, such as Klebsiella pneumoniae. The Company’s agents focus on the therapeutics, including antivirals, antifungals, antiparasitics and antimicrobials, which can treat the hospital and community acquired infections caused by multi-drug resistant pathogens.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Disease Bacteria Infection Antibiotic Antimicrobial Anti Infectives Antibiotics Organisms Antivirals Biocides Infections Infectious Disease

Is APLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.08
52 Week Low 0.025
Average Volume 119,391
200-Day Moving Average 0.040
50-Day Moving Average 0.031
20-Day Moving Average 0.032
10-Day Moving Average 0.033
Average True Range 0.003
RSI (14) 60.78
ADX 16.25
+DI 31.567
-DI 37.097
Chandelier Exit (Long, 3 ATRs) 0.031
Chandelier Exit (Short, 3 ATRs) 0.034
Upper Bollinger Bands 0.039
Lower Bollinger Band 0.026
Percent B (%b) 0.7
BandWidth 41.486
MACD Line 0.000
MACD Signal Line 0.001
MACD Histogram -0.0002
Fundamentals Value
Market Cap 2.18 Million
Num Shares 62.3 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 280.78
Price-to-Book 3.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.035
Resistance 3 (R3) 0.035 0.035 0.035
Resistance 2 (R2) 0.035 0.035 0.035 0.035
Resistance 1 (R1) 0.035 0.035 0.035 0.035 0.035
Pivot Point 0.035 0.035 0.035 0.035 0.035
Support 1 (S1) 0.035 0.035 0.035 0.035 0.035
Support 2 (S2) 0.035 0.035 0.035 0.035
Support 3 (S3) 0.035 0.035 0.035
Support 4 (S4) 0.035